Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JW 1-3 test compounds in a psoriasis transplant model
NL-OMON46431Active, not recruiting
- Sponsor
- Derphartox
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of JW 1-3 in psoriasis, sponsored by Derphartox. Started Apr 2018; status: active, not recruiting.
02
Drugs
JW 1-3
03
Conditions
psoriasis
Beyond the preview
Go deeper on NL-OMON46431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46431.